As of 2025-07-08, the EV/EBITDA ratio of Moderna Inc (MRNA) is -3.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 9,999.94 mil USD. MRNA's TTM EBITDA according to its financial statements is -3,079.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 11.1x | 9.4x |
| Forward P/E multiples | 7.8x - 11.5x | 9.8x |
| Fair Price | (58.56) - (84.20) | (72.02) |
| Upside | -295.9% - -381.6% | -340.9% |
| Date | EV/EBITDA |
| 2025-07-07 | -3.25 |
| 2025-07-03 | -3.32 |
| 2025-07-02 | -3.30 |
| 2025-07-01 | -3.10 |
| 2025-06-30 | -2.96 |
| 2025-06-27 | -2.90 |
| 2025-06-26 | -2.95 |
| 2025-06-25 | -2.87 |
| 2025-06-24 | -2.86 |
| 2025-06-23 | -2.72 |
| 2025-06-20 | -2.75 |
| 2025-06-18 | -2.68 |
| 2025-06-17 | -2.70 |
| 2025-06-16 | -2.76 |
| 2025-06-13 | -2.84 |
| 2025-06-12 | -2.93 |
| 2025-06-11 | -2.98 |
| 2025-06-10 | -2.97 |
| 2025-06-09 | -3.03 |
| 2025-06-06 | -2.94 |
| 2025-06-05 | -2.77 |
| 2025-06-04 | -2.92 |
| 2025-06-03 | -2.99 |
| 2025-06-02 | -2.89 |
| 2025-05-30 | -2.83 |
| 2025-05-29 | -2.87 |
| 2025-05-28 | -2.76 |
| 2025-05-27 | -2.85 |
| 2025-05-23 | -2.79 |
| 2025-05-22 | -2.85 |
| 2025-05-21 | -2.73 |
| 2025-05-20 | -3.01 |
| 2025-05-19 | -2.81 |
| 2025-05-16 | -2.61 |
| 2025-05-15 | -2.46 |
| 2025-05-14 | -2.51 |
| 2025-05-13 | -2.69 |
| 2025-05-12 | -2.72 |
| 2025-05-09 | -2.54 |
| 2025-05-08 | -2.55 |
| 2025-05-07 | -2.51 |
| 2025-05-06 | -2.56 |
| 2025-05-05 | -2.99 |
| 2025-05-02 | -2.96 |
| 2025-05-01 | -2.89 |
| 2025-04-30 | -3.08 |
| 2025-04-29 | -2.99 |
| 2025-04-28 | -2.94 |
| 2025-04-25 | -2.91 |
| 2025-04-24 | -2.93 |